Prof Bertrand Tombal (Saint-Luc Hospital, Brussels, Belgium) and Dr Mark Beresford (Royal United Hospitals Bath, Bath, UK) have a focused discussion looking at overall safety of treatment and current predictive markers within prostate cancer at ESMO 2016.
The experts initially discuss the...
Published 08/03/17
ecancer Editor in Chief, Prof Gordon McVie provides us with a roundup of all the ESMO 2016 highlights.
Prof McVie discusses the following:
Prof Alexander Eggermont - ipilimumab for melanoma
Dr Arjun Balar - pembrolizumab for urothelial cancer
Dr Gabriel Hortobagyi - ribociclib for breast...
Published 08/03/17